Quick Answer
Tevogen Bio Holdings Inc. reported Earnings Per Share Diluted of $8.08 (loss) per share for the year ending 2025.
- Tevogen Bio Holdings Inc. showed a decrease of -130.9% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Tevogen Bio Holdings Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2023 to 2025), Tevogen Bio Holdings Inc.'s Earnings Per Share Diluted has declined by 231.1%.
- Historical annual values: Fiscal year 2025: $8.08 (loss) per share | Fiscal year 2024: $3.50 (loss) per share | Fiscal year 2023: $2.44 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: